GlaxoSmithKline Accused of Market 'Abuse' over Antidepressant Drug
By Geetha Pillai | April 19, 2013 7:46 PM EST
Pharmaceutical giant GlaxoSmithKline has said that it had acted "within the law" by entering in to deals with generic drug makers to delay the release of their versions of antidepressant paroxetine.
"GSK supports fair competition and we very strongly believe that we acted within the law, as the holder of valid patents for paroxetine, in entering the agreements under investigation," GSK said in a statement in response to the allegations of the Office of Fair Trading (OFT).
According to the OFT, GSK made payments to three generic companies as part of a deal over the drug which it sells under the brand name Seroxat, used to treat depression.
The consumer watchdog alleged that the drug maker infringed competition law by entering into agreement with Alpharma, Generics UK and Norton Healthcare.
But the company said "these arrangements resulted in other paroxetine products entering the market before GSK's patents had expired.
"We have cooperated fully with the Office of Fair Trading in this investigation, which covers activities that happened between 2001 and 2004. The paroxetine supply agreements under investigation were terminated in 2004.
"The OFT investigation covers matters that have already been investigated by the European Commission in 2005-2006. In March 2012 the Commission announced that it had formally concluded its enquiry with no further action.
"The issues were also reviewed in the European Commission's 2008-2009 Sector Inquiry. Neither investigation resulted in any sanctions against the company".
However, the OFT investigation is focusing on whether or not any competition law has been infringed by the actions of GSK, which has the market dominance, by delaying the entry of generic versions of the drug.
The introduction of generic medicines can lead to strong competition on price, which can drive savings for the NHS, to the benefit of patients and, ultimately, taxpayers," said Ann Pope, senior director of services, infrastructure and public markets at the OFT.
"It is therefore particularly important that the OFT fully investigates concerns that independent generic entry may have been delayed in this case."
To contact the editor, e-mail:
Most Popular Slideshows
- Real Life ‘Frozen’: Snow Overwhelms The US, Kills 7; More To Come (Pictures)
- Angelina Jolie, Brad Pitt in Sydney for ‘Unbroken’ Red Carpet Premiere [PHOTOS]
- ‘The Walking Dead’ Season 5, Episode 8 Spoilers: Daryl Dixon Is Set To Burn The Place Down in ‘Coda’
- G20 Summit Awkward Moments: Putin Yawns, Mystery Bubbles Appear, F18 Drama Ensues
Join the Conversation
- Air Canada Expands Vancouver Boeing 787 Dreamliners To Beijing, Seoul, Shanghai, Tokyo-Narita Routes
- Canada Consumer Alert: Tim Hortons Prices Of Coffee, Sandwiches To Go Up Effective Nov 26
- Doomsday Seed Vault Safeguards More Marijuana Seeds
- Travel Alert: Malaysia’s AirAsia Cuts Number Of Australian Flights
- Australia, NZ Ditch Proposed Joint Therapeutic Products Agency
- Walmart Early Price Matching Special Event On Nov. 21, 2014 Matches Its Competitors' Black Friday 2014 Prices And Includes Exclusive Deals For Samsung LED HDTVs And iPad Air 2 [WATCH VIDEO]
- US Plane Flying Over Russian Skies Spotted; Vladimir Putin Ready For 'Practical Cooperation' With US
- Alleged 'Microsoft Lumia 1030' Front Panel Leaked With Capacitive Buttons; 'Xbox One' Owners To Get Free Goodies On Anniversary
- Nexus 6 Release Date And Price Under AT&T, T-Mobile And Sprint Listed
- Walmart Pre-Black Friday 2014 Sale On Nov. 21, 2014 Includes Discounts On The 'NBA 2K15' For PS4 And The 'Skylanders Trap Team’ Starter Kit [WATCH VIDEO]
- Cold War 2: Russia, China And North Korea’s Blacklisted Company Fortify Alliance -- Reports
- Black Friday 2014 Sale: Top Deals On Game Consoles Xbox One, PS4, Nintendo Wii U And More